Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Total Non-Current Liabilities: 2010-2025

Historic Total Non-Current Liabilities for Myriad Genetics (MYGN) over the last 15 years, with Sep 2025 value amounting to $353.6 million.

  • Myriad Genetics' Total Non-Current Liabilities rose 12.15% to $353.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $353.6 million, marking a year-over-year increase of 12.15%. This contributed to the annual value of $324.3 million for FY2024, which is 0.71% up from last year.
  • According to the latest figures from Q3 2025, Myriad Genetics' Total Non-Current Liabilities is $353.6 million, which was up 23.08% from $287.3 million recorded in Q2 2025.
  • Myriad Genetics' 5-year Total Non-Current Liabilities high stood at $440.6 million for Q2 2023, and its period low was $235.1 million during Q2 2022.
  • Its 3-year average for Total Non-Current Liabilities is $337.3 million, with a median of $322.0 million in 2023.
  • As far as peak fluctuations go, Myriad Genetics' Total Non-Current Liabilities plummeted by 44.93% in 2022, and later spiked by 87.41% in 2023.
  • Quarterly analysis of 5 years shows Myriad Genetics' Total Non-Current Liabilities stood at $320.8 million in 2021, then decreased by 16.15% to $269.0 million in 2022, then climbed by 19.70% to $322.0 million in 2023, then rose by 0.71% to $324.3 million in 2024, then climbed by 12.15% to $353.6 million in 2025.
  • Its Total Non-Current Liabilities was $353.6 million in Q3 2025, compared to $287.3 million in Q2 2025 and $299.2 million in Q1 2025.